APP and Alzheimer disease: Sirt1 is thought to be neuroprotective, and its expression is reduced in neurodegenerative disorders; it is involved in AD-like physiopathogenic mechanisms, including neuroinflammation, APP processing, and mitochondrial dysfunction [22, 23].